Åsa Riisberg

Åsa Riisberg

Directeur/Bestuurslid bij NETCOMPANY GROUP A/S
52 jaar
Finance
Health Technology
Technology Services

Profiel

Åsa Hallert Riisberg is currently Chairman at Atlas Antibodies AB since 2021.
Director at Bonnier AB since 2022.
Director at Atos Medical Holding AB. Non-Executive Director at Dagens Nyheter AB since 2020.
Director at Internetmedicin Holding AB since 2021.
Director at Patricia Industries AB since 2022.
Director at Bonnier News AB since 2019.
Independent Director at Netcompany Group A since 2020.
Independent Director at Swedish Orphan Biovitrum AB starting 2026.
Advisory Board Member at Handelshögskoleföreningen i Stockholm.
Advisory Board Member at Chiesi GmbH since 2021.
Former roles include Independent Director at WithSecure Corp.
Director at ABG Sundal Collier Holding ASA from 2018 to 2021.
Independent Non-Executive Director at Corden Pharma Fribourg SA. Director at Karo Healthcare AB in 2019.
Director at Atos Medical AB. Director at Aleris Sjukvård AB from 2005 to 2010.
Director at Brande 3.
juli 2024 A. Director at Atos Medical Holding 2 AB. Director at JKF Industri A. Director at Holdingselskabet AF 24 Februar 2006 A. Director at FlexLink AB from 2001 to 2005.
Director at Swedish Private Equity & Venture Capital Association.
Director at SSP Ltd. (United Kingdom) from 2006 to 2008.
Director at Cimbria Bulk Technology A. Director at Starid Holding 1 AB. Director at Terveystalo Oyj.
Director at Starid Holding 2 AB. Director at Starid Holding 3 AB. Director at F-Secure Oyj from 2021 to 2022.
Analyst at Morgan Stanley.
Partner at EQT Partners AB from 2001 to 2020.
Member-Supervisory Board at HTL-STREFA SA. Head-Shareholder Relations at EQT AB. Member-Supervisory Board at EQT Credit BV, EQT Oppgrechec BV, EQT Opportunity Equity BV, EQT Opportunity Holdings BV, EQT V Equity BV, SEP Holdings BV, Tilsted Holding BV, and Tilsted BV.
Investment Committee Member at Cinder Invest AB from 2020 to 2022.
Associate at TPG Capital.
Education includes a graduate degree from Stockholm School of Economics conferred in 1997.

Actieve functies van Åsa Riisberg

BedrijvenFunctieBegin
NETCOMPANY GROUP A/S Directeur/Bestuurslid 19-08-2020
SWEDISH ORPHAN BIOVITRUM AB Directeur/Bestuurslid 06-05-2026
Voorzitter -
Directeur/Bestuurslid 01-02-2019
Directeur/Bestuurslid 01-10-2020
Directeur/Bestuurslid 01-03-2022
Directeur/Bestuurslid 01-05-2022
Handelshögskoleföreningen i Stockholm
Directeur/Bestuurslid -
Directeur/Bestuurslid 01-10-2021
░░░░░░░░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░░░░░░░░ -

Eerdere bekende functies van Åsa Riisberg

BedrijvenFunctieEinde
░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░ ░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░ ░░░░░░░ ░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░ ░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░░░░ ░ ░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Ervaring van Åsa Riisberg in detail bekijken

Opleiding van Åsa Riisberg

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

86

Eerstegraads connecties

45

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit45

Finance

Technology Services

Finance

Health Technology

Consumer Non-Durables

Consumer Services

Finance

Health Technology

Handelshögskoleföreningen i Stockholm

Consumer Services

Health Technology

Health Services

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Electronic Technology

Holdingselskabet AF 24 Februar 2006 A/S

Consumer Services

Producer Manufacturing

Health Technology

Internetmedicin Holding AB

Commercial Services

Finance

Technology Services

Producer Manufacturing

Finance

Finance

Retail Trade

Health Services

Finance

Finance

Finance

Finance

Finance

Finance

Finance

Finance

Finance

Miscellaneous

Technology Services

Finance

Finance

Technology Services

  1. Beurs
  2. Insiders
  3. Åsa Riisberg
DE LAATSTE UREN | -40 %: De beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU